computational

Digital

BIO-Europe Spring podcast with Kashif Sadiq

Creating what nature has not from AI and computational molec...

Kashif Sadiq, founder and CEO of DenovAI Biotech discusses harnessing the power of artificial intelligence and computational molecular biophysics.

Digital

BIO-Europe Spring interview with Dr Olga Nissan

On collaboration, computational chemistry, and cutting-edge ...

R&D

pharmaphorum podcast Episode 230, Benedict Cross, PhoreMost

Harnessing the cell's own degradation machinery, with Benedi...

Benedict Cross, Chief Technology Officer at PhoreMost, discusses targeted protein degradation.

News

Protein misfolding specialist Gain nets $40m from IPO

Gain Therapeutics has priced its initial public offering, raising more than $40 million for its computational drug discovery platform and pipeline of drugs for diseases associated with prot

Events

4070_CDD_For_Biologics_Event_Banner_800x450

Partner Content

3rd Annual Computational Drug Development (CDD) for Biologic...

CDD for Biologics | 13-15 November 2018 | Boston, USA

Creating what nature has not from AI and computational molec...

On collaboration, computational chemistry, and cutting-edge ...

Harnessing the cell's own degradation machinery, with Benedi...

Protein misfolding specialist Gain nets $40m from IPO

3rd Annual Computational Drug Development (CDD) for Biologic...

LSX2026: On promise and patience, with Hans Schambye

Using AI-driven synthetic personas to take your insights fur...

computational

Editor's Picks